NVSEF fundamentals
An in-depth look to Novartis AG operating, investing, and financing activities
NVSEF free cash flow for Q1 24 is 1.98 B USD. For 2023, NVSEF free cash flow was 14.3 B USD and operating cash flow was 15.43 B USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM